The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

North America held the largest convalescent plasma therapy market share.

The global convalescent plasma therapy market is expected to grow from $0.04 billion in 2022 to $0.05 billion in 2023 at a compound annual growth rate (CAGR) of 11.4%. The global convalescent plasma therapy market size is expected to grow from $0.07 billion in 2027 at a CAGR of 12.0%.

Major Driver In The Convalescent Plasma Therapy Market ­– Higher Efficacy And Safety Evaluated During The Trials Conducted For CPT In COVID-19 Patients
The results of a research conducted by Houston Methodist Hospital in June 2020, which aimed to evaluate the safety and efficacy of COVID-19 convalescent plasma therapy, stated that the convalescent plasma therapy is safe, with no side effects reported, and efficient, with a 76% recovery rate. A study published in the Journal of Medical Virology in May 2020 stated that convalescent plasma therapy may reduce mortality in critically ill patients, have beneficial effects on clinical symptoms, increase neutralising antibody titers, and result in the disappearance of SARS-CoV-2 RNA. Convalescent plasma therapy’s safety and efficacy in COVID-19 patients will drive market expansion.

View More On The Convalescent Plasma Therapy Market Report 2023 – https://www.thebusinessresearchcompany.com/report/convalescent-plasma-therapy-global-market-report

Key Convalescent Plasma Therapy Market Segments
1) By Application: Prophylaxis, Treatment
2) By End-Users: Hospitals & Clinics, Laboratories & Research institutes
3) By Antibody type: IgM, IgG, IgA

Recent Convalescent Plasma Therapy Market Trend – Developing Antibody-Based Immunotherapy
Convalescent plasma therapy uses the donor’s antibodies against coronavirus to boost the recipient’s immunity. Companies are starting trials, partnering, and investing in COVID-19 antibody treatment. GSK announced a relationship with Vir Biotechnology in April 2020, investing $250 million in Vir to support the development of anti-viral antibody-based therapies against new coronaviruses. In April 2020, the Biomedical Advanced Research Development Authority (BARDA) partnered with Emergent BioSolutions to fund $14.5 million to support the development of COVID-Human Immune Globulin (COVID-HIG), a human plasma-derived therapy for treating COVID-19 in severely hospitalised and high-risk patients. CSL Behring, Takeda Pharmaceutical Company Limited, Biotest, BPL, LFB, and Octapharma cooperated in April 2020 to develop plasma-derived COVID-19 Hyperimmune Therapy. Because convalescent plasma therapy employs antibodies, the emphasis on antibody-based COVID-19 therapy is projected to drive market expansion.

Convalescent Plasma Therapy Market Prominent Players
Major players in the convalescent plasma therapy market are Bio Farma, Grifols, Hilton Pharma, Biotest, BPL, LFB, Octapharma, CSL Behring, Takeda Pharmaceutical Company Limited and Orthosera Kft.

Request A Sample Of The Global Convalescent Plasma Therapy Market Report 2023:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3233&type=smp

The Convalescent Plasma Therapy Global Market Report 2023  provides a comprehensive overview on the convalescent plasma therapy market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the convalescent plasma therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Convalescent plasma is plasma that has antibodies against the infection-causing microbe and has been taken from persons who have recovered or are convalescing.It is used to treat patients who have been infected with the relevant infection.

View More Related Reports –
Plasma Therapy Global Market Report 2023
Plasma Fractionation Global Market Report 2023
Plasma Protein Therapeutics Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model